Photocure launches European Hexvix operations
Oslo, Norway, 1 October 2020: Photocure ASA (OSE:PHO) today announces the commencement of the sales, marketing and distribution of Hexvix[®] in the European markets formerly operated by Ipsen Pharma SAS (Ipsen). The successful transition and launch of European Hexvix operations creates a robust platform for accelerated growth and expansion for Photocure."We are proud to announce the launch of our European Hexvix operations which will transform Photocure into a strong global business within the diagnosis and treatment of bladder cancer. We have built a successful commercial organization for